期刊文献+

氯吡格雷联合阿托伐他汀治疗不稳定型心绞痛47例临床观察 被引量:4

Clinical observation of clopidogrel combined with atorvastatin on 47 cases with unstable angina pectoris
下载PDF
导出
摘要 目的探讨氯吡格雷联合阿托伐他汀治疗不稳定型心绞痛的临床疗效。方法选择笔者所在医院2008年1月~2009年11月不稳定型心绞痛患者94例,随机将上述患者分为两组,观察组和对照组。对照组患者给予阿司匹林、美托洛尔、硝酸甘油、钙拮抗剂和低分子肝素等常规抗心绞痛治疗,观察组在对照组用药基础上给予阿托伐他汀和氯吡格雷,两组患者均治疗4周。结果两组患者治疗后,总有效率比较,差异有统计学意义(P<0.05)。结论氯吡格雷联合阿托伐他汀治疗不稳定型心绞痛临床效果显著,值得临床借鉴。 Objective To explore the clinical efficacy of clopidogrel combined with atorvastatin on unstable angina pectoris. Methods 94 cases with unstable angina pectoris were selected from January 2008 to November 2009, which were randomly divided into two groups, observation group and contrel group. Aspirin, metoprelol, nitroglycerin, calcium antagonist and low molecular weight heparin were used to the control group, on the base of the therapy of control group, clopidogrel combined with atorvastatin was given to observation group, the course was 4 weeks in two groups. Results The total of clinical efficacy in observation compared with that in control group, there was statistical difference ( P 〈 0.05 ). Conclusion Clopidogrel combined with atorvastatin on unstable angina pectoris has significantly clinical efficacy, and the therapy should be the reference for doctors.
作者 殷淑娟
出处 《中国医学创新》 CAS 2010年第32期35-37,共3页 Medical Innovation of China
关键词 不稳定型心绞痛 氯吡格雷 阿托伐他汀 Unstable angina pectoris Clopidogrel Atorvastatin
  • 相关文献

参考文献4

二级参考文献17

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2赵凤兰.舒降之、低分子肝素、氯比格雷联合治疗不稳定型心绞痛的疗效观察[J].临床医学,2005,25(5):6-7. 被引量:14
  • 3Pasceri-V, Willerson-J-T, Yeh-E-T. Direct proinfammatory effect of C-reactive protein on human endothelial cells. Circulation, 2000,102 ( 18 ): 2165 -2168.
  • 4Biasueei-L-M, Collizzi-C, Rizzello-V, et al. Role of inflammation in the pathogenesis of unstable coronary atery disease [ J ]. Scand-J-Clin-Lab-Invest-Suppl, 1999,230 : 12- 22.
  • 5Correia LC, Sposito AC, Lima JC, et al. Antiinflammatory effect of atorvastatin (80mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction [ J ]. Am J Cardiol. 2003,92 (3) :298-301.
  • 6Ostadal P, Alan D, Haijek D, et al. The effect of early treatment by cerivastatin in the serum level of C-reactive protein,interleukin-6 and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction[ J]. Mol Cell Biochen,2003,246 (1-2) :45-50.
  • 7Chyrchel M, Dudek D, Bartus S, et al. High-dose statin and COX-2 inhibitor therapy rapidly decrease C-reactive protein level in patients with unstable angina [ J ]. Kardiol pol,2004,61 (9):213-221.
  • 8Luigi M, Giovanna L, Rita L, et al. Elevated levels of C- reactive protein at discharge in patients with unstable angina predict recurrent instability[J]. Clin Invest Rep, 1998, 11:855-859.
  • 9Folson AR, Aleksic N, Cateller D, et al. C-reactive protein and incident coronary risk in communities (ARIC) study [ J ]. Am Heart J, 2002,144 ( 2 ) : 233-237.
  • 10Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guide lines for the management of patients with ustable angina and non - ST -segment elevation myocardial infarction[ J]. J Am Coll Cardiol, 2000,36:970 - 1062.

共引文献101

同被引文献55

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2Rinaldi B, Donniacuo M, Esposito E, et al.PPAR c: mediates the anti-in-flammatory effect of simvastatin in an experimental model of zymosan-in-duced multiple organ failure[J].Br J Pharmacol, 2011, 163 ( 3 ) : 609-623.
  • 3Parizadeh S M, Azarpazhooh M R, Moohebati M, et al.Simvastatin therapy reduces prooxidant-antioxidant balance; results of a placebo- controlled cross-over trial[J].Lipids, 2011, 46 ( 4 ) : 333-340.
  • 4Pedemen TR, Cater NB, Faergeman 0,et al. Comparisonof atorvastatin 80 mg/day versus sim vastafin 20 to 40 mg/day on frequency of cardiovascular events late (fiveyears) after acute myocardial infarction (from the Incre-mental Decrease in End Points through Aggressive LipidLowering [IDEALJtrial [J]. Am J Cardiol,2010,106(3):354-359.
  • 5Li X,Liu XH,Nie SP,et al. Prognostic value of baselineC-reactive protein levels in patients undergoing coronaryrevaseularization [J]. Chin Med J (Engl) ,2010,123 (13):1628-1632.
  • 6Cubeddu LX, Alfieri AB,Hoffmann IS. Lowering the thresh-old for defining microalbuminuria : effects of a lifestyle -metformin intervention in obese/normoalbuminuriconon -diabetic subjects [J]. Am J Hypertens,2008,21(1):105-110.
  • 7Shiyanagi S,Okazaki T,Shoji H,et al. Management ofpulmonary hypertension in congenital diaphragmatic her-nia: nitric oxide with prostaglandin-El versus nitric ox-ide alone [J], Pediatric Surgery International, 2008,24(10):1101-1104.
  • 8Karatzis EN,Ikonomidis I,Vamvakou GD,et al. Long-term prognos-tie role of flow-mediated dilatation of thebrachial artery after acute coronary syndromes withoutST elevation [J]. Am J Cardiol,2006,98(ll) ; 1424-1428.
  • 9叶毅敏.他汀类药物治疗不稳定型心绞痛对血清超敏C-反应蛋白的影响及其临床意义[J].海南医学院学报,2009,15(4):332-333. 被引量:10
  • 10史晓静,陶贵周.不同剂量阿托伐他汀对不稳定型心绞痛预后的影响[J].医学综述,2009,15(12):1886-1888. 被引量:13

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部